Will Opko Health stock go up?

According to Danelfin AI, Opko Health has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (50.95%) is +0.13% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Opko Health stock?

The Opko Health target price is $3.71 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Opko Health stock right now?

Opko Health has today a Hold rating (AI Score 4/10), according to Danelfin AI. Its probability of beating the market in 3 months (50.95%) is +0.13% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Opko Health stock is a good buy .

Is Opko Health undervalued right now?

Based on analysts, the average price target upside for Opko Health is +145.75% (1Y). According to Danelfin AI, Opko Health has today an AI Score of 4/10 (Hold Rating).

What was the price range of Opko Health stock over the past 12 months?

The Opko Health stock price range over the past 12 months has been $1.1 - $1.58.

What is going on with Opko Health stock in the last 3 months?

The Opko Health stock performance in the last quarter has been +32.45%.

Does Opko Health offer dividend payments?

No, Opko Health does not currently pay dividends.

What is the current market capitalization of Opko Health?

Opko Health's market cap is $1.16B, as of 2026-07-02 08:00.

When is the next OPK earnings report date?

OPK will publish its next earnings report on 2026-04-28.

OPKO Health Inc (OPK) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

OPK AI-Powered Stock Analysis

AI Score Explanation

AI Score

Hold

Fundamental
Technical
Sentiment
Low Risk

According to Danelfin’s proprietary AI model, OPKO Health Inc today receives an AI Score of 4/10, which translates to a Hold rating. The stock has a 51% probability of outperforming the market in the next 3 months, which is 1% higher than the average probability of any stock (50%). Among the top positive contributors, the Fundamentals Impact (Long Tail) adds +0.19% to the probability, while the Chart Pattern (504d) and Technicals Impact (Long Tail) each contribute +0.16%. On the negative side, the Chart Pattern (180d) detracts -0.13%, the Industry (GICS) (Health Care Providers & Services) detracts -0.12%, and the Sentiment Impact (Long Tail) also detracts -0.12%. Notable data points include the Fear & Greed Index at 31 (indicating fear), which negatively impacts the probability, and the Earnings Countdown at -59 days (bottom 20%), which positively influences the stock. The ATR (14d Volatility) is in the bottom 10% (low volatility), adding +0.05% to the probability, while the Analyst Lowest Price Upside is in the top 40% (upside of 4.58%), but detracts -0.04%. Overall, the stock’s probability is only slightly above average, with mixed signals from fundamentals and technicals, resulting in a neutral HOLD rating.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Momentum+0.19%
Direction and strength of recent price movements
Valuation+0.16%
How the stock is priced relative to its fundamentals
Volatility+0.08%
How much the stock price tends to fluctuate
Earnings Quality+0.05%
Stability and reliability of reported earnings
Size & Liquidity+0.03%
Company size and trading liquidity

Sentiment-0.34%
How analysts and the market view the stock
Profitability-0.03%
Profitability and operating efficiency metrics

OPK probability advantage of beating the market (3M):

+0.13%

AI Score

Hold

Opko Health (OPK) has an AI Score of 4/10 (Hold) because, according to an overall analysis, it has a probability advantage of +0.13% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of OPK (50.95%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
OPK probability advantage of beating the market (3M)+0.13%
OPK probability of beating the market (3M)50.95%

OPK probability advantage of beating the market (3M): +0.13%

The AI-powered overall analysis of Opko Health (OPK) is based on the 28 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of OPK:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+0.19%
Technical	Chart Pattern (504d)	figure_76	N/A	+0.16%
Technical	Technicals Impact (Long Tail)	-	N/A	+0.16%
Technical	Chart Pattern (180d)	figure_13	N/A	-0.13%
Sentiment	Industry (GICS)	Health Care Providers & Services	N/A	-0.12%
Sentiment	Sentiment Impact (Long Tail)	-	N/A	-0.12%
Sentiment	Fear & Greed Index (CNN)	31	N/A	-0.10%
Sentiment	Earnings Countdown	-59		+0.06%
Technical	Chart Pattern (252d)	figure_89	N/A	-0.05%
Technical	ATR (14d Volatility)	0.06	N/A	+0.05%
Fundamental	Upgrade to unlock			+0.05%
Technical	Upgrade to unlock			-0.04%
Sentiment	Upgrade to unlock			-0.04%
Technical	Upgrade to unlock			-0.04%
Sentiment	Upgrade to unlock			-0.04%

Rest of Alpha Signals: +0.12%

OPK probability advantage of beating the market (3M)Total:+0.13%
OPK AI Score

Significant changes Vs previous day

OPK Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$1.51
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

OPK Proven Hold Signal & Price Forecast

This is the price chart for OPK from January 1, 2026 until today. The chart indicates, in yellow, the 92 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

OPK Average Past Performance & Win Rate

Three months after its 1374 Hold signals since July 2026, OPK had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

1374 Past OPK Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				-2.43%
Average Alpha				-17.20%
Win Rate (% Positive Perf.)				29.21%
% Positive Alpha				20.40%

OPK Frequently Asked Questions

Will Opko Health stock go up?
According to Danelfin AI, Opko Health has today an AI Score of 4/10 (Hold rating), because its probability of beating the market in 3 months (50.95%) is +0.13% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Opko Health stock?
Is it a good time to buy, sell, or hold Opko Health stock right now?
Is Opko Health undervalued right now?
What was the price range of Opko Health stock over the past 12 months?
What is going on with Opko Health stock in the last 3 months?
Does Opko Health offer dividend payments?
What is the current market capitalization of Opko Health?
When is the next OPK earnings report date?

OPKO Health Inc Company Profile

OPKO Health, Inc. is a healthcare enterprise that conducts business in the pharmaceutical and diagnostic arenas across multiple international markets such as the USA, Ireland, Chile, Spain, Israel, and Mexico. The Diagnostic arm operates under BioReference Laboratories offering testing facilities for the early detection, diagnosis, continuous monitoring, and treatment of various diseases. This includes esoteric testing facilities, molecular diagnostics, anatomical pathology services as well as specialized features like women’s health-focused packages and correctional healthcare. Its arsenal also boasts of 4Kscore prostate cancer test among other specialized options.

On its Pharmaceutical front line, it showcases Rayaldee - a medication aimed at alleviating secondary hyperparathyroidism in adults suffering from stage 3 or 4 chronic kidney disease coupled with vitamin D deficiency. Furthermore, it houses the infrastructure currently working on creating multi-specific immune therapies with emphasis on anti-cancer treatments, infectious diseases methods sosolutions to immunology discrepancies, and vaccines.

The catalogue covers OPK88003 used for managing type II diabetes and consequential obesity; followed by Somatrogon (hGH-CTP), a once-a-week human growth hormone injection; along with FactorVIIa-CTP which serve as an innovative coagulation factor aiming to solve haemophilia-related issues. The company also prides itself on recreating better versions of pre-existing approved therapeutic proteins while manufacturing specialty APIs.

In addition to this broad range of pharmaceutical services that include nutraceuticals products and Ophthalmic solutions to veterinary medicines and supplemental nutrition products - this globe-spanning corporation delivers generic market oriented medical goods while ensuring consistent sales traction for drugs encompassing cardiovascular therapy solutions iroundinating vaccinesobservable medicationsgastrointestinal boutsolving hormones amongst others under its commercial umbrella spread across Ireland ChileSpainMexicoweavingan intricate pharmaceutical fabric around retailers distributorsPIOko was established in th1991atheadquartersfirmly rootedMiamiFlorida_flankson-the-waem_plosesne_models.

Sector:
Country:United States
Industry:

Pros

Proprietary diagnostic test intellectual property

Specialty pharmaceutical product market niches

Established global commercial infrastructure

Diversified product pipeline across segments

Potential for diagnostic platform clinical guideline integration

Cons

High research and development capital intensity

Pros

Cons

Company	AI Score	Compare
SOPHSOPHiA GENETICS SA

Company

AI Score

Compare

SOPHSOPHiA GENETICS SA

Company

AI Score

Compare

OPK Top 10 Industry Stocks

Health Care Providers & Services

	Company	AI Score	Compare
1	ENSGEnsign Group Inc
2	BKDBrookdale Senior Living Inc
3	NHCNational Healthcare Corp
4	VMDViemed Healthcare Inc
5	ARDTArdent Health Inc
6	EHCEncompass Health Corp
7	HCAHCA Healthcare Inc
8	MCKMcKesson Corp
9	CICigna Group
10	NUTXNutex Health Inc

	Company	AI Score	Compare

	Company	AI Score	Compare
1	COGTCogent Biosciences Inc

Company

AI Score

Compare

COGTCogent Biosciences Inc

Company

AI Score

Compare

OPK Stock AI Analysis

OPKO Health Inc

OPK Stock AI Analysis

OPKO Health Inc

OPK AI-Powered Stock Analysis

AI Score Explanation

AI Score Explanation

Generating AI Score explanation

AI Score Alpha Factors

Alpha Signals: What Drives the AI Score

OPK probability advantage of beating the market (3M): +0.13%

OPK Trading Parameters

OPK Proven Hold Signal & Price Forecast

OPK Average Past Performance & Win Rate

OPK Frequently Asked Questions

Will Opko Health stock go up?

What is the target price for Opko Health stock?

Is it a good time to buy, sell, or hold Opko Health stock right now?

Is Opko Health undervalued right now?

What was the price range of Opko Health stock over the past 12 months?

What is going on with Opko Health stock in the last 3 months?

Does Opko Health offer dividend payments?

What is the current market capitalization of Opko Health?

When is the next OPK earnings report date?

OPKO Health Inc Company Profile

Pros

Cons

Pros

Cons

OPK Company Profile Summary

OPK Related Investment Themes

OPK Related Stocks

OPK Top 10 Industry Stocks

Health Care Providers & Services

OPK Top 10 Sector Stocks

Health Care

OPK Stock AI Analysis

OPKO Health Inc

NASDAQ NMS - GLOBAL MARKET

Will Opko Health stock go up?

What is the target price for Opko Health stock?

Is it a good time to buy, sell, or hold Opko Health stock right now?

Is Opko Health undervalued right now?

What was the price range of Opko Health stock over the past 12 months?

What is going on with Opko Health stock in the last 3 months?

Does Opko Health offer dividend payments?

What is the current market capitalization of Opko Health?

When is the next OPK earnings report date?

Pros

Cons

NASDAQ NMS - GLOBAL MARKET

AI Score Explanation

OPK Proven Hold Signal & Price Forecast